Request for Information (Rfi) - Ninds Division Translational Research - Continuous... Tender

Procurement Summary

Country : USA

Summary : Request for Information (Rfi) - Ninds Division Translational Research - Continuous Rodent and Non-Rodent Pharmacokinetic (Pk) Assessments

Deadline : 15 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 98696723

Document Ref. No. : 75N95024R00062

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contracting Office Address : Bethesda, MD 20892
Primary Point of Contact : Sneha Singh
sneha.singh@nih.gov

USA
Email :sneha.singh@nih.gov

Tender Details

Description

See Attached PDF.

REQUEST FOR INFORMATION



Solicitation Number: 75N95024R00062



Title: NINDS Division Translational Research - Continuous Rodent and Non-Rodent Pharmacokinetic (PK) Assessments



Classification Code: Q301 Medical - Laboratory Testing

NAICS Code: 541380 Testing Laboratories and Services

Size Standard: $19M



Description:

This is a Request for Information (RFI). This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this RFI is to obtain knowledge and information for programs planning purposes.



The Government is also considering NAICS 325414 Biological Product (except Diagnostic) Manufacturing, Size Standard 1, 250 employees.



Background: The National Institute of Neurological Disorders and Stroke (NINDS) and the NIH Blueprint Neurotherapeutics Network (BPN) (http://neuroscienceblueprint.nih.gov/bpdrugs/index.htm) have established a ‘virtual pharma' network of contract service providers and consultants with extensive industry experience to enable therapeutic (e.g., small molecule, peptide, biologic) development in the NIH research community. This network has a need to run routine pharmacokinetic studies in support of the program. Studies are mostly iv/po rodent studies but information on capabilities to run other routes of administration and other species is also of interest.



Purpose and Objectives: The NINDS is interested in identifying commercial sources with capabilities and qualifications that could run routine rodents pharmacokinetic (PK) testing for the purposes of new therapeutics developments. Additionally, information capabilities to run dog PK and other routes of administration is also sought.



Requirements: (See Attached PDF )

Please describe your organization-s ability to perform the following tasks and answer the following questions:

Is your organization a small business as defined by the SBA? What ...
Active Contract Opportunity Notice ID 75N95024R00062 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Mar 11, 2024 04:12 pm EDT
Original Response Date: Apr 15, 2024 11:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Apr 30, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code:
NAICS Code: 541380 - Testing Laboratories and Services

Place of Performance: Bethesda, MD USA

Documents

 Tender Notice

NINDS-PK-RFI.pdf